BfR Warns Against Infant Vitamin D Overdose, Questions Elderly Supplement Need

Bonn, Germany — 26 August 2026

The German Federal Institute for Risk Assessment (BfR) has issued two significant pronouncements impacting the supplement sector, focusing on Vitamin D safety in infants and the general necessity of micronutrient supplements for the elderly. On 07 August 2026, the BfR cautioned against excessive Vitamin D intake in infants, specifically warning of hypervitaminosis D, which can lead to severe health complications. This alert underscores the critical need for precise dosage control and clear consumer guidance for infant-targeted Vitamin D products, often administered via drops. Misinterpretation of dosage instructions or improper administration can lead to concentrations far exceeding safe limits.

Separately, on 24 August 2026, the BfR released guidance on micronutrient supplements for the elderly. The institute stated that healthy older individuals generally meet their nutritional requirements through a balanced diet, implying that routine supplementation is largely unnecessary. While acknowledging specific cases where supplementation may be beneficial, such as existing medical conditions or medication use, the BfR emphasised that such decisions should be made in consultation with a physician. This position signals a more conservative regulatory stance on broad-spectrum supplements for healthy seniors.

These advisories from a prominent EU member state regulator like the BfR carry weight beyond Germany. The BfR frequently collaborates with the European Food Safety Authority (EFSA), and its scientific opinions often inform broader European regulatory dialogues and consumer protection initiatives. Manufacturers supplying the German or wider EU market should anticipate increased scrutiny on product formulations, labelling, and marketing claims for both infant Vitamin D and general senior health supplements.

What this means for Germany

German manufacturers must immediately review infant Vitamin D product formulations and labelling to prevent hypervitaminosis, including clear dosing instructions and warning statements to mitigate litigation risk. Brand owners targeting the elderly should prepare for potential market contraction for non-specific, preventative supplements, with a shift towards products addressing clinical deficiencies or specific health outcomes as advised by medical professionals. The BfR's statements may prompt tighter advertising standards from the Federal Office of Consumer Protection and Food Safety (BVL), potentially requiring substantiation for all health claims, impacting marketing budgets and go-to-market strategies within the next 12-18 months. Procurement leads should assess ingredient sourcing for quality and purity to avoid contamination that could exacerbate toxicity concerns.

Many leading brands in this category are manufactured in partnership with Supplement Factory.